UPDATE: Hedge Fund Manger Kyle Bass Wins Right to Challenge Four Patents on Acorda's (ACOR) Ampyra
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Wall St stocks end higher with major corporate earnings in view
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Cadence (CDNS) tumbles despite Q1 beat on top and bottom lines
- Tesla expands price cuts to China, Germany after reducing FSD cost; shares down
- Gold prices slide as M.East fears ease, rate jitters persist
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
Acorda Therapeutics (ACOR) Confirms PTAB Institutes IPRs of AMPYRA Patents
March 11, 2016 3:48 PM ESTAcorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that the United States Patent and Trademark Office (USPTO)... More
Acorda Therapeutics (ACOR) Drops; Kyle Bass's IPR Review Said Instituted Against Acorda '703 Patent
March 11, 2016 2:37 PM ESTAcorda Therapeutics (NASDAQ: ACOR) Drops; Kyle Bass's IPR Review Said Instituted Against '703 Ampyra Patent
$ACOR Kyle Bass Coalition IPR review INSTITUTED against challenged Acorda '703 Ampyra patent. (3 others due) https://t.co/W4dlTFoMP6
TradeHawk (@TradeHawk) March 11, 2016... More
